Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
893 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06267378 | Assessing Frailty and Its Impacts on Patients Facing Major GI Surgery | recruiting | — | 100 | Doncaster And Bassetlaw Hospitals NHS Foundation TrustOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT04050345 | Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer(TRACC) | recruiting | — | 1,000 | Royal Marsden NHS Foundation TrustOTHER | 1 |
| Jun 14, 2024 |
| clinicaltrials |
| NCT06423976 | Microbiome Molecular Charaterisation(MMC) | recruiting | — | 1,000 | Institute of Cancer Research, United KingdomOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT04625907 | FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma(FaR-RMS) | recruiting | Phase 1 / Phase 2 | 1,672 | University of BirminghamOTHER | 20 | May 23, 2024 | clinicaltrials |
| NCT04061512 | Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia(RAINBOW) | recruiting | Phase 2 / Phase 3 | 148 | University College, LondonOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT03914378 | The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD)(EARAD) | recruiting | — | 100 | University of ManchesterOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06401304 | Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)(OncoPROValue-1) | recruiting | — | 1,200 | Uppsala UniversityOTHER | 3 | May 6, 2024 | clinicaltrials |
| NCT06357416 | The Man Van Project(MV) | recruiting | N/A | 4,000 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT04493632 | OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.(OSPREY) | recruiting | — | 500 | OncoSil Medical LimitedINDUSTRY | 2 | Apr 30, 2024 | clinicaltrials |
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)(BoB) | recruiting | Phase 2 | 1,000 | Vall d'Hebron Institute of OncologyOTHER | 7 | Apr 25, 2024 | clinicaltrials |
| NCT05080556 | Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer(ACTOv) | recruiting | Phase 2 | 80 | University College, LondonOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT04128072 | Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma(MOGAT) | recruiting | Phase 2 | 43 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Apr 5, 2024 | clinicaltrials |
| NCT05085028 | A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)(REFINE-Lung) | recruiting | Phase 3 | 1,750 | Imperial College LondonOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT04253015 | A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta | recruiting | — | 125 | RECORDATI GROUPINDUSTRY | 7 | Feb 7, 2024 | clinicaltrials |
| NCT04723316 | Tumour Characterisation to Guide Experimental Targeted Therapy - National | recruiting | — | 6,000 | The Christie NHS Foundation TrustOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT04790253 | PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)(PRIMALung) | recruiting | N/A | 600 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Nov 3, 2023 | clinicaltrials |
| NCT06065852 | National Registry of Rare Kidney Diseases(RaDaR) | recruiting | — | 35,000 | UK Kidney AssociationOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT03997643 | Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial | recruiting | Phase 2 | 90 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 4 | Aug 3, 2023 | clinicaltrials |
| NCT05968417 | Myeloma Novel Drug Discovery Ver 1.2(DISCO) | recruiting | — | 250 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT02193841 | Simple Bone Cysts in Kids(SBoCK) | recruiting | Phase 3 | 160 | The Hospital for Sick ChildrenOTHER | 4 | Jul 12, 2023 | clinicaltrials |
| NCT05058183 | Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer(Safe-De) | recruiting | N/A | 400 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05432739 | Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study | recruiting | — | 500 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05231135 | A Registry Study on HIV-related Lymphoma | recruiting | — | 300 | Rotkreuzklinikum München gGmbHOTHER | 4 | Apr 6, 2023 | clinicaltrials |
| NCT05696002 | Advanced Pelvic Surgical Oncology Database - Prospective Observational Study | recruiting | — | 300 | Glasgow Royal InfirmaryOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT05693116 | Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule(NV-SCC) | recruiting | — | 300 | Istituto Clinico HumanitasOTHER | 3 | Jan 20, 2023 | clinicaltrials |
| NCT04442334 | The European NAFLD Registry | recruiting | — | 10,000 | Newcastle UniversityOTHER | 12 | Jan 6, 2023 | clinicaltrials |
| NCT03150576 | Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer(PARTNER) | recruiting | Phase 2 / Phase 3 | 780 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT05541601 | Prospective Cohort for Early Detection of Liver Cancer(Pearl) | recruiting | — | 3,000 | University of OxfordOTHER | 1 | Sep 15, 2022 | clinicaltrials |
| NCT05534906 | The Detection of Small Early Liver Cancer With Natural History Follow up(SELINA) | recruiting | — | 250 | University of OxfordOTHER | 1 | Sep 10, 2022 | clinicaltrials |
| NCT04502394 | Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL | recruiting | Phase 1 / Phase 2 | 84 | Kartos Therapeutics, Inc.INDUSTRY | 11 | Aug 4, 2022 | clinicaltrials |
| NCT04595019 | Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer(HERMES) | recruiting | N/A | 46 | Institute of Cancer Research, United KingdomOTHER | 1 | Jun 13, 2022 | clinicaltrials |
| NCT05375591 | AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer(AI-SONAR) | recruiting | — | 1,000 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT05363657 | International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors(i-RECORd) | recruiting | — | 10,000 | Azienda Ospedaliero-Universitaria CareggiOTHER | 13 | May 6, 2022 | clinicaltrials |
| NCT04946773 | Deep Liver Phenotyping and Immunology Study(DELPHI) | recruiting | — | 100 | University of OxfordOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT04190849 | European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)(EU-PNAFLD) | recruiting | — | 2,000 | Cambridge University Hospitals NHS Foundation TrustOTHER | 2 | Mar 4, 2022 | clinicaltrials |
| NCT05177562 | Reproductive Endocrinology Oxford Study (RepOx)(RepOx) | recruiting | — | 1,175 | University of OxfordOTHER | 1 | Jan 4, 2022 | clinicaltrials |
| NCT04060706 | Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy(Hamlet rt) | recruiting | — | 310 | CCTU- Cancer ThemeOTHER | 1 | Aug 2, 2021 | clinicaltrials |
| NCT01704716 | High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) | recruiting | Phase 3 | 3,300 | St. Anna KinderkrebsforschungOTHER | 20 | Oct 23, 2020 | clinicaltrials |
| NCT03288532 | Renal Adjuvant MultiPle Arm Randomised Trial(RAMPART) | recruiting | Phase 3 | 1,750 | University College, LondonOTHER | 1 | Sep 7, 2020 | clinicaltrials |
| NCT04493723 | Serial Tumour Biopsies and Blood Biomarkers in Melanoma | recruiting | — | 300 | The Christie NHS Foundation TrustOTHER | 1 | Jul 30, 2020 | clinicaltrials |
| NCT03838718 | REtroperitoneal SArcoma Registry: an International Prospective Initiative(RESAR) | recruiting | — | 2,000 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 11 | Feb 12, 2019 | clinicaltrials |
| NCT03562169 | The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd) | recruiting | Phase 3 | 406 | University of LeedsOTHER | 1 | Jun 19, 2018 | clinicaltrials |
| NCT01194648 | Focal Therapy for Prostate Cancer Using HIFU(INDEX) | recruiting | N/A | 354 | University College, LondonOTHER | 1 | Apr 20, 2018 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials